For more than 30 years, the Eurofins Cosmetics & Personal Care network of companies has been growing, achieving a leadership position by embracing new testing methods and services. As part of our sustainable vision, we are passionate about collaborating with partners to develop game-changing innovations and new testing perspectives to better serve our clients. Thus, we strongly believe that working together is the key to building and accelerating the next generation of in vitro testing.

Eurofins Cosmetics & Personal Care focuses on building long-term, transparent and trusted partnerships with strategic companies that have the experience, expertise, knowledge and capabilities to support future in vitro innovation. Our diverse collaborations encompass cutting-edge, leading European start-ups that encourage entrepreneurial thinking, including:

  • CTIBIOTECH provides 3D Bioprinted full skin models (production of 50 to 100 artificial skin models from skin cells from a single donor), in vitro models (different human cell types from skin pre-clinical grade production) and ex vivo biopsy models (including skin, scalp, hair and on-demand tissues).
  • Phenocell provides in vitro assays to Dermatology and Ophtalmology Research, based on breakthrough iPS cells
  • Bionos provides efficacy testing for Cosmetic and Food-Nutraceutical industries, mainly in in vitro and ex vivo bioassays, by using cutting-edge equipment and techniques at their facilities at the Hospital La Fe in Valencia, Spain.

These three partnerships complement Eurofins Cosmetics & Personal Care’s current global offering and form part of the companies’ global strategy to provide a one-stop shop solution and deliver superior and sustainable solutions.

For further information:

https://www.eurofins.com/cosmetics/media-centre/news/eurofins-cosmetics-personal-care-is-building-a-sustainable-and-innovative-future-together-with-strategic-in-vitro-partnerships/